CVS Earnings & Financial Statements
CVS Health Corporation
$90.39
+$2.84(+3.24%)
62
Overall
80
Value
45
Tech
63
Quality
Market Cap
$111.97B
Volume
9.02M
52W Range
$69.51 - $110.68
Target Price
$114.17
CVS earnings and financial statements: CVS Health Corporation's income statement, balance sheet and cash flow statement, annual and quarterly.
CVS Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $402.07B | $372.81B | $357.78B | $322.47B | $292.11B |
| Cost of revenue | $221.17B | $206.29B | $217.10B | $196.89B | $239.99B |
| Operating income | $4.66B | $8.52B | $13.74B | $7.95B | $13.19B |
| EBITDA | $9.86B | $13.70B | $18.20B | $12.35B | $17.53B |
| Net income | $1.77B | $4.61B | $8.34B | $4.31B | $8.00B |
| EPS (diluted) | $1.39 | $3.66 | $6.47 | $3.14 | $5.95 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $253.54B | $253.22B | $249.73B | $228.28B | $233.00B |
| Total liabilities | $178.16B | $177.49B | $173.09B | $156.51B | $157.62B |
| Shareholders’ equity | $75.21B | $75.56B | $76.46B | $71.47B | $75.08B |
| Cash and equivalents | $8.45B | $8.59B | $8.20B | $12.95B | $9.41B |
| Long-term debt | $74.14B | $75.43B | $74.67B | $67.28B | $70.15B |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $10.64B | $9.11B | $13.43B | $16.18B | $18.27B |
| Capital expenditure | -$2.83B | -$2.78B | -$3.03B | -$2.73B | -$2.52B |
| Free cash flow | $7.81B | $6.33B | $10.39B | $13.45B | $15.74B |
| Dividends paid | $3.40B | $3.37B | $3.13B | $2.91B | $2.63B |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CVS | $90.39 | +3.2% | 9.02M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |